# Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis

> **NCT00222534** · PHASE4 · COMPLETED · sponsor: **University of Oslo School of Pharmacy** · enrollment: 70 (actual)

## Conditions studied

- Respiratory Insufficiency
- Alkalosis

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00222534
- **Lead sponsor:** University of Oslo School of Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2014-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222534, "Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00222534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*